Cargando…

Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index

BACKGROUND: Predicting the prognosis of patients with solitary fibrous tumor (SFT) is often difficult. The prognostic risk models developed by Demicco et al. are now the standard for evaluating the risk of SFT metastasis in the current World Health Organization classification of soft tissue and bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugita, Shintaro, Segawa, Keiko, Kikuchi, Noriaki, Takenami, Tomoko, Kido, Tomomi, Emori, Makoto, Akiyama, Yukinori, Takada, Kohichi, Hinotsu, Shiro, Hasegawa, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805435/
https://www.ncbi.nlm.nih.gov/pubmed/35105348
http://dx.doi.org/10.1186/s12957-022-02497-2
_version_ 1784643251816366080
author Sugita, Shintaro
Segawa, Keiko
Kikuchi, Noriaki
Takenami, Tomoko
Kido, Tomomi
Emori, Makoto
Akiyama, Yukinori
Takada, Kohichi
Hinotsu, Shiro
Hasegawa, Tadashi
author_facet Sugita, Shintaro
Segawa, Keiko
Kikuchi, Noriaki
Takenami, Tomoko
Kido, Tomomi
Emori, Makoto
Akiyama, Yukinori
Takada, Kohichi
Hinotsu, Shiro
Hasegawa, Tadashi
author_sort Sugita, Shintaro
collection PubMed
description BACKGROUND: Predicting the prognosis of patients with solitary fibrous tumor (SFT) is often difficult. The prognostic risk models developed by Demicco et al. are now the standard for evaluating the risk of SFT metastasis in the current World Health Organization classification of soft tissue and bone tumors. METHODS: In this study, we examined the prognostic usefulness of a modified version of the Demicco risk models that replaces the mitotic count with the Ki-67 labeling index. We compared the three-variable and four-variable Demicco risk models with our modified risk models using Kaplan–Meier curves based on data for 43 patients with SFT. RESULTS: We found a significant difference in metastasis-free survival when patients were classified into low-risk and intermediate/high-risk groups using the three-variable (P = 0.022) and four-variable (P = 0.046) Demicco models. There was also a significant difference in metastasis-free survival between the low-risk and intermediate/high-risk groups when the modified three-variable (P = 0.006) and four-variable (P = 0.022) models were used. CONCLUSION: Modified risk models that include the Ki-67 labeling index are effective for prediction of the prognosis in patients with SFT.
format Online
Article
Text
id pubmed-8805435
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88054352022-02-03 Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index Sugita, Shintaro Segawa, Keiko Kikuchi, Noriaki Takenami, Tomoko Kido, Tomomi Emori, Makoto Akiyama, Yukinori Takada, Kohichi Hinotsu, Shiro Hasegawa, Tadashi World J Surg Oncol Research BACKGROUND: Predicting the prognosis of patients with solitary fibrous tumor (SFT) is often difficult. The prognostic risk models developed by Demicco et al. are now the standard for evaluating the risk of SFT metastasis in the current World Health Organization classification of soft tissue and bone tumors. METHODS: In this study, we examined the prognostic usefulness of a modified version of the Demicco risk models that replaces the mitotic count with the Ki-67 labeling index. We compared the three-variable and four-variable Demicco risk models with our modified risk models using Kaplan–Meier curves based on data for 43 patients with SFT. RESULTS: We found a significant difference in metastasis-free survival when patients were classified into low-risk and intermediate/high-risk groups using the three-variable (P = 0.022) and four-variable (P = 0.046) Demicco models. There was also a significant difference in metastasis-free survival between the low-risk and intermediate/high-risk groups when the modified three-variable (P = 0.006) and four-variable (P = 0.022) models were used. CONCLUSION: Modified risk models that include the Ki-67 labeling index are effective for prediction of the prognosis in patients with SFT. BioMed Central 2022-02-01 /pmc/articles/PMC8805435/ /pubmed/35105348 http://dx.doi.org/10.1186/s12957-022-02497-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sugita, Shintaro
Segawa, Keiko
Kikuchi, Noriaki
Takenami, Tomoko
Kido, Tomomi
Emori, Makoto
Akiyama, Yukinori
Takada, Kohichi
Hinotsu, Shiro
Hasegawa, Tadashi
Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index
title Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index
title_full Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index
title_fullStr Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index
title_full_unstemmed Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index
title_short Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index
title_sort prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the ki-67 labeling index
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805435/
https://www.ncbi.nlm.nih.gov/pubmed/35105348
http://dx.doi.org/10.1186/s12957-022-02497-2
work_keys_str_mv AT sugitashintaro prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT segawakeiko prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT kikuchinoriaki prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT takenamitomoko prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT kidotomomi prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT emorimakoto prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT akiyamayukinori prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT takadakohichi prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT hinotsushiro prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex
AT hasegawatadashi prognosticusefulnessofamodifiedriskmodelforsolitaryfibroustumorthatincludestheki67labelingindex